Marmara Eczacılık Dergisi - 2010; 14(2) - Current Issue http://www.marmaraeczacilikrgisi.com Marmara Pharmaceutical Journal - RSS feed of Current Issue March 2010 Marmara Pharmaceutical Journal <![CDATA[Oxytocin and hypothalamo-pituitaryadrenal axis]]> http://www.marmaraeczacilikdergisi.com/text.php3?id=243 2010-03-01 Marmara Pharmaceutical Journal 2 14 066 2010-03-01 061 Review <![CDATA[Protective effect of erdosteine against naphthalene-induced oxidative stress in rats]]> http://www.marmaraeczacilikdergisi.com/text.php3?id=244 2010-03-01 Marmara Pharmaceutical Journal 2 14 073 2010-03-01 067 Original Article <![CDATA[Study of the antibiotic prescription practice for safety purposes for inpatients hospitalized due to pneumonia]]> http://www.marmaraeczacilikdergisi.com/text.php3?id=245 2010-03-01 Marmara Pharmaceutical Journal 2 14 078 2010-03-01 074 Original Article <![CDATA[Synthesis of some novel hydrazone derivatives and evaluation of their antituberculosis activity]]> http://www.marmaraeczacilikdergisi.com/text.php3?id=246 2010-03-01 Marmara Pharmaceutical Journal 2 14 083 2010-03-01 079 Original Article <![CDATA[Synthesis and cytotoxic activity of some 1,2,4-triazoline-3-thione and 2,5-disubstituted- 1,3,4-thiadiazole derivatives]]> http://www.marmaraeczacilikdergisi.com/text.php3?id=247 2010-03-01 Marmara Pharmaceutical Journal 2 14 090 2010-03-01 084 Original Article <![CDATA[Glycyl-L-Histidyl-L-Liysine-Cu(2+) loaded liposome formulations]]> http://www.marmaraeczacilikdergisi.com/text.php3?id=248 2010-03-01 Marmara Pharmaceutical Journal 2 14 097 2010-03-01 091 Original Article <![CDATA[GC-MS analysis of fluoxetine and its active metabolite norfluoxetine in human urine]]> http://www.marmaraeczacilikdergisi.com/text.php3?id=249 -1 for fluoxetine and 6-125 ng mL -1 for norfluoxetine by solid phase extraction (SPE), and 10-80 ng mL -1 for fluoxetine and also norfluoxetine by liquid- liquid extraction (LLE). Also the range of detection limits were between 1-10 ng mL -1 , the range of quantification limits were between 5-10 ng mL -1 for fluoxetine and norfluoxetine by both SPE and LLE. The range of recoveries were between 87 -109 % by both SPE and LLE for analytes. The developed method allowed clinical and toxicological analysis of fluoxetine and norfluoxetine in urine samples.]]> 2010-03-01 Marmara Pharmaceutical Journal 2 14 103 2010-03-01 098 Original Article